Company intelligence / Profile preview

Cypris Medical

Chicago, Illinois, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Cypris Medical's ARC and Xact devices allow minimally-invasive lifting and suturing of facial tissues (including the SMAS) to treat facial aging, with the potential to achieve face/neck lift outcomes in the office with rapid recovery. Clinical trials were initiated for the Xact device to validate safety and efficacy for midface descent.

Therapeutic areas: OtherDermatology
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Allergan Aesthetics (option to acquire and partnership on Xact device clinical program)[4]

Beyond the preview

Go deeper on Cypris Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cypris Medical.

Explore the full profile